These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11854810)

  • 1. Misoprostol and Prednisone Treatment of Lupus Nephritis.
    Belmont HM; Kitsis E; Skovron ML; Buyon J; McCullagh E; Abramson S
    Am J Ther; 1995 Dec; 2(12):928-932. PubMed ID: 11854810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: findings of a prospective, randomized, double-blind, placebo-controlled trial.
    Tseng CE; Buyon JP; Kim M; Belmont HM; Mackay M; Diamond B; Marder G; Rosenthal P; Haines K; Ilie V; Abramson SB
    Arthritis Rheum; 2006 Nov; 54(11):3623-32. PubMed ID: 17075807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Misoprostol on Contrast-Induced Renal Dysfunction.
    Gurkowski L; MacDougall M; Wiegmann T
    Am J Ther; 1995 Nov; 2(11):837-842. PubMed ID: 11854796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leflunomide versus cyclophosphamide in the induction treatment of proliferative lupus nephritis in Chinese patients: a randomized trial.
    Zhang M; Qi C; Zha Y; Chen J; Luo P; Wang L; Sun Z; Wan J; Xing C; Wang S; Jiang G; Sun M; Chen Q; Chen J; Li D; Guan T; Ni Z
    Clin Rheumatol; 2019 Mar; 38(3):859-867. PubMed ID: 30426311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Influence of Misoprostol on the Adverse Renal Effects and Stereospecific Pharmacokinetics of Ibuprofen in Chronic Renal Insufficiency.
    Rudy DW; Rudy AC; Black PK; Liu Y; Hamman M; Brater DC
    Am J Ther; 1995 Nov; 2(11):864-874. PubMed ID: 11854800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tobramycin Serum Concentrations After Aerosol and Oral Administration in Cystic Fibrosis.
    Weber A; Williams-Warren J; Ramsey B; Smith AL
    Am J Ther; 1995 Feb; 2(2):81-87. PubMed ID: 11847533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Subcutaneous Belimumab in Anti-Double-Stranded DNA-Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus.
    Doria A; Stohl W; Schwarting A; Okada M; Scheinberg M; van Vollenhoven R; Hammer AE; Groark J; Bass D; Fox NL; Roth D; Gordon D
    Arthritis Rheumatol; 2018 Aug; 70(8):1256-1264. PubMed ID: 29671280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein and complement components but not other acute-phase reactants discriminate between clinical subsets and organ damage in systemic lupus erythematosus.
    Amezcua-Guerra LM; Springall R; Arrieta-Alvarado AA; Rodríguez V; Rivera-Martinez E; Castillo-Martinez D; Bojalil R
    Clin Lab; 2011; 57(7-8):607-13. PubMed ID: 21888025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abetimus sodium for renal flare in systemic lupus erythematosus: results of a randomized, controlled phase III trial.
    Cardiel MH; Tumlin JA; Furie RA; Wallace DJ; Joh T; Linnik MD;
    Arthritis Rheum; 2008 Aug; 58(8):2470-80. PubMed ID: 18668592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney Outcomes and Risk Factors for Nephritis (Flare/
    Buyon JP; Kim MY; Guerra MM; Lu S; Reeves E; Petri M; Laskin CA; Lockshin MD; Sammaritano LR; Branch DW; Porter TF; Sawitzke A; Merrill JT; Stephenson MD; Cohn E; Salmon JE
    Clin J Am Soc Nephrol; 2017 Jun; 12(6):940-946. PubMed ID: 28400421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Gender and Menopausal Status on the Pharmacokinetics of Tirilazad Mesylate in Healthy Subjects.
    Fleishaker JC; Hulst-Pearson LK; Peters GR
    Am J Ther; 1995 Aug; 2(8):553-560. PubMed ID: 11854826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Pharmacokinetics of the Neuroprotective Agent NBQX.
    Ingwersen SH; Ohrström JK; Petersen P; Drustrup J; Bruno L; Nordholm L
    Am J Ther; 1994 Dec; 1(4):296-303. PubMed ID: 11835103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose--Response Study of Colestipol Tablets in Patients with Moderate Hypercholesterolemia.
    Hunninghake DB; Stein EA; Bremner WF; Greenland P; Demke DM; Oliphant TH
    Am J Ther; 1995 Mar; 2(3):180-189. PubMed ID: 11847550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prednisone monotherapy induced remission in a group of patients with membranous lupus nephritis.
    Bitencourt Dias C; Pinheiro CC; Malafronte P; Titan S; Alves de Brito G; Gera Abrão J; Dos Santos Silva V; Toledo Barros R; Woronik V
    Clin Nephrol; 2011 Jul; 76(1):57-63. PubMed ID: 21722606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Food on the Pharmacokinetics and Pharmacodynamics of Torsemide.
    Kramer WG
    Am J Ther; 1995 Jul; 2(7):499-503. PubMed ID: 11850698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Laboratory and morphologic parameters in patients with lupus nephritis].
    Rasković S; Bogić M; Perić-Popadić A; Stefanović L; Arandjelović S; Jovicić Z; Bolpacić J; Tomić-Spirić V
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of biomarkers that predict response to treatment of lupus nephritis with mycophenolate mofetil or pulse cyclophosphamide.
    Dall'Era M; Stone D; Levesque V; Cisternas M; Wofsy D
    Arthritis Care Res (Hoboken); 2011 Mar; 63(3):351-7. PubMed ID: 21080348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics in Non-Insulin-Dependent Diabetics of the Aldose Reductase Inhibitor, Zopolrestat.
    Inskeep PB; Reed AE; Connolly AG; Wilner KD; Vargas R; McMahon FG
    Am J Ther; 1995 Feb; 2(2):112-118. PubMed ID: 11847537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term tacrolimus-based immunosuppressive treatment for young patients with lupus nephritis: a prospective study in daily clinical practice.
    Tanaka H; Watanabe S; Aizawa-Yashiro T; Oki E; Kumagai N; Tsuruga K; Ito E
    Nephron Clin Pract; 2012; 121(3-4):c165-73. PubMed ID: 23327881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.